EFORT

EFORT Webinar

CELL-FREE PRODUCTS IN OA: SECRETOM, EVS AND EXOSOMES

The data requested in the below form is needed for the generation of your certificate of attendance, please provide the details of your name as you want to be reflected in your personal attendance certificate.

Please provide your online registration details:

Date and time

Monday
24
November
19:00 CET
SIGN-UP NOW!


​​​​​​​EFORT Webinar
CELL-FREE PRODUCTS IN OA:
SECRETOM, EVS AND EXOSOMES

Webinar Chair 
Prof. Laura DE GIROLAMO, PhD | Italy​​​​​​​


​​​​​​​19:00-19:02 | Introduction
Prof. Laura DE GIROLAMO, PhD | Director of REGAIN - REgenerative GAleazzi INstitute | Milan, Italy 

19:02-19:17 | Tiny vesicles, big effect: exploring the basic biology of exosomes 
Dr. Enrico Ragni | Galeazzi Sant'Ambrogio Hospital | Milan - Italy

19:17-19:32 | Impact of cultivation method of mesenchymal stromal cells on the therapeutic efficacy of extracellular vesicles
Prof. Andrea De Luna | Center for Regenerative Medicine, University for Continuing Education Krems | Krems an Der Donau - Austria

19:32-19:47 | Generation EV: inheriting MSC parental potential while avoiding their clinical roadblocks
Prof. Maroun Khoury | Nano-regenerative Laboratory, Biomedical Investigastion and Innovation Center (CiiB)  University de los Andes | Santiago, Chile

19:47-19:58 | Questions and Answers | All Webinar Audience

19:8-20:00 | Final Remarks
Prof. Laura DE GIROLAMO, PhD | Director of REGAIN - REgenerative GAleazzi INstitute | Milan, Italy 
The Next Horizon in Orthobiologics: Moving Beyond the Cell.

Join us for a definitive session bridging the lab bench and the bedside. This webinar will analyse the cutting-edge science and emerging clinical application of cell-free therapeutics for Osteoarthritis (OA)—the most promising area of musculoskeletal regeneration.

The objectives of this Webinar are:
  • Understand Exosome Fundamentals and Mechanisms
    - Explain the basic biology of exosomes ("Tiny vesicles, big effect"), including their origin, composition, and role as key mediators in cell-to-cell communication.
    - Articulate the specific mechanisms by which exosomes exert their therapeutic effects (e.g., anti-inflammatory, regenerative) in the context of joint disease.
  • Analyze Production and Potency Factors
    - Evaluate the significant impact of mesenchymal stromal cell (MSC) cultivation methods on the quantity, quality, and resultant therapeutic efficacy of their derived Extracellular Vesicles (EVs).
    - Identify the critical production variables that researchers and developers must control to ensure consistent and potent cell-free OA biotherapeutics.
  • Assess Clinical and Safety Data
    - Appraise the current scientific and clinical evidence regarding the safety and efficacy of exosome biotherapeutics specifically for the treatment of joint disease.
    - Discuss the major challenges and considerations necessary for the clinical translation of exosome-based therapies, including regulatory pathways and safety monitoring in patients.

Duration: 60 minutes

ADD TO YOUR CALENDAR

****

This Webinar is organised by EFORT independent of any commercial educational support. ​​​​You can view it from your computer, tablet or mobile phone.

****

MORE INFORMATION ABOUT EFORT WEBINARS:
https://www.efort.org/webinars​​​​​

Share this webinar